HVIVO
LIVE

Serial Number

79169697

Owner

HVIVO SERVICES LIMITED

Attorney

Mainak H. Mehta

Filing Date

May 1, 2015

Add to watchlist:

No watchlists yet
View on USPTO

HVIVO Trademark

Serial Number: 79169697 • Registration: 5815659

HVIVO is a trademark filed by HVIVO SERVICES LIMITED on May 1, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

HVIVO SERVICES LIMITED (15 trademarks)

Queen Mary BioEnterprises Innovation Centre,

Entity Type: 99

Trademark Details

Filing Date

May 1, 2015

Registration Date

July 30, 2019

Published for Opposition

May 14, 2019

Goods & Services

[ Pharmaceutical and medical compositions for human and/or veterinary use, namely, clinical medical reagents, medical diagnostic reagents, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; diagnostic preparations and substances for medical purposes; medical diagnostic reagents; antiserums for diagnostic purposes for medical purposes; vaccines for human beings and/or animals; adjuvants for use with vaccines; biological laboratory preparations for medical and/or veterinary purposes, namely, clinical medical reagents, medical diagnostic reagents, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; chemical preparations for medical, pharmaceutical and veterinary purposes, namely, clinical medical reagents, medical diagnostic reagents, biochemical reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays; chemical reagents for medical, pharmaceutical and veterinary purposes; viruses for the treatment of humans and/or animals, namely, viruses for use as an ingredient in vaccines for preventing and treatment of influenza or HRV or RSV; diagnostic preparations for medical purposes; in-vitro diagnostic reagents for medical purposes; in-vivo reagents for diagnostic medical purposes ]

Medical research services; conducting clinical trials for others; medical research laboratory services; scientific analysis and research services, namely scientific research; product development relating to pharmaceuticals, medicines, medicaments and veterinary products; medical and health care research services in the field of clinical testing services, physician testing services for assisting pharmacists, pharmacy testing services, medical laboratory and testing services; medical research into the causes and treatment of influenza and the common cold; research services in the field of medical diagnostics; medical laboratory services for the analysis of samples taken from patients for research purposes

Business investigation and research services relating to cost and business efficiency, all relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; systemization and compilation of medical information into computer databases; providing statistical information for business purposes, all of said information relating to pharmaceuticals, medicine, medicines, vaccines, science, bacteriology, toxicology, chemistry, clinicology, oncology, biochemistry and biotechnology; registration services for diagnostic testing, namely, services consisting of the registration, collection, transcription, compilation and systemization of written communications and data with respect to diagnostic testing; product demonstration services in the field of diagnostic testing; computer database management services, including information storage and retrieval services in the fields of diagnostic testing and preparations for the treatment, monitoring or diagnosis of disease; trade information services in the fields of medical, health, or clinical care; database management of diagnostic testing and results, database management of medical, hospital, insurance or billing records; collation and provision of business information for the purpose of providing referral services in the fields of medical, health or clinical care; collation and provision of business information regarding results from diagnostic testing in relation to medicine and pharmacy; collation and provision of business information regarding medical and pharmaceutical testing procedures; collation and provision of business information regarding disease conditions and disease prevention; collation and provision of business information regarding medical, hospital, insurance or billing records

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
May 22, 2026 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
May 22, 2026 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 18, 2026 APRE
TEAS SECTION 71 RECEIVED
Jan 20, 2026 ES71
INTERNATIONAL REGISTRATION RENEWED
May 1, 2025 RNWL
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 30, 2024 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 30, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Nov 6, 2019 FICS
FINAL DISPOSITION PROCESSED
Nov 6, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 30, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 30, 2019 R.PR
NOTIFICATION PROCESSED BY IB
May 31, 2019 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 14, 2019 NPUB
PUBLISHED FOR OPPOSITION
May 14, 2019 PUBO
NEW REPRESENTATIVE AT IB RECEIVED
May 9, 2019 NREP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 24, 2019 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2019 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 24, 2019 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 2, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 21, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2019 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 21, 2019 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 2, 2018 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 1, 2018 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 20, 2017 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 19, 2017 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 20, 2017 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 4, 2017 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 4, 2017 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 13, 2016 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 7, 2016 RCSC
ASSIGNED TO LIE
Mar 22, 2016 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Sep 22, 2015 GNS3
LETTER OF SUSPENSION E-MAILED
Sep 22, 2015 GNSL
SUSPENSION LETTER WRITTEN
Sep 22, 2015 CNSL
REFUSAL PROCESSED BY IB
Sep 18, 2015 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 18, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 17, 2015 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 27, 2015 RFCS
REFUSAL PROCESSED BY MPU
Aug 27, 2015 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 27, 2015 RFCR
NON-FINAL ACTION WRITTEN
Aug 26, 2015 CNRT
ASSIGNED TO EXAMINER
Aug 13, 2015 DOCK
APPLICATION FILING RECEIPT MAILED
Aug 11, 2015 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 6, 2015 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 30, 2015 REPR